NL6708204A - - Google Patents

Info

Publication number
NL6708204A
NL6708204A NL6708204A NL6708204A NL6708204A NL 6708204 A NL6708204 A NL 6708204A NL 6708204 A NL6708204 A NL 6708204A NL 6708204 A NL6708204 A NL 6708204A NL 6708204 A NL6708204 A NL 6708204A
Authority
NL
Netherlands
Application number
NL6708204A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6708204A publication Critical patent/NL6708204A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL6708204A 1966-06-23 1967-06-13 NL6708204A (cs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55971266A 1966-06-23 1966-06-23
US56092466A 1966-06-23 1966-06-23

Publications (1)

Publication Number Publication Date
NL6708204A true NL6708204A (cs) 1967-12-27

Family

ID=27072136

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6708204A NL6708204A (cs) 1966-06-23 1967-06-13

Country Status (13)

Country Link
US (2) US3438968A (cs)
BE (1) BE700231A (cs)
CH (1) CH487166A (cs)
DE (1) DE1695278A1 (cs)
DK (1) DK122670B (cs)
ES (1) ES341109A1 (cs)
FR (1) FR6729M (cs)
GB (1) GB1167993A (cs)
GR (1) GR33409B (cs)
IL (1) IL28164A (cs)
NL (1) NL6708204A (cs)
NO (1) NO125632B (cs)
SE (1) SE357561B (cs)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2068522A1 (cs) * 1969-08-28 1971-08-27 Newport Pharmaceuticals

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1458586A (en) * 1974-01-29 1976-12-15 Beecham Group Ltd Antiviral complexes of double stranded rna and its derivatives
FR2260331B1 (cs) * 1974-02-08 1978-01-13 Mauvernay Centre Europ Rech
JPH0669953B2 (ja) * 1985-08-16 1994-09-07 日産化学工業株式会社 脳脊髄系神経栄養剤
US5091432A (en) * 1990-03-28 1992-02-25 Glasky Alvin J 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use
WO1996003125A1 (en) 1994-07-25 1996-02-08 Glasky Alvin J Carbon monoxide dependent guanylyl cyclase modifiers
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
US5801184A (en) * 1994-07-25 1998-09-01 Glasky; Alvin J. Carbon monoxide dependent guanylyl cyclase modifiers and methods of use
US5447939A (en) * 1994-07-25 1995-09-05 Glasky; Alvin J. Carbon monoxide dependent guanylyl cyclase modifiers and methods of use
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) * 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
DE60144123D1 (de) 2000-07-07 2011-04-07 Spectrum Pharmaceuticals Inc Verfahren zur Behandlung von Arzneimittelinduzierter peripherer Neuropathie und verwandten Krankheitsformen
US6759427B2 (en) * 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3070606A (en) * 1962-12-25 Xchxn
US3068222A (en) * 1962-12-11 Trifluoromethyl substituted dibenzxze-
US1678429A (en) * 1926-08-25 1928-07-24 Soc Of Chemical Ind Organic gold compounds and process of making same
FR769M (cs) * 1960-11-25 1961-08-28
GB1083911A (en) * 1964-01-13 1967-09-20 Chugai Pharmaceutical Co Ltd Adenosine triphosphate salts of l-ornithine and process for preparing the same
US3326892A (en) * 1965-04-16 1967-06-20 Irwin I Lubowe Allantoin sodium ribonucleinate

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2068522A1 (cs) * 1969-08-28 1971-08-27 Newport Pharmaceuticals

Also Published As

Publication number Publication date
DK122670B (da) 1972-03-27
IL28164A (en) 1971-11-29
DE1695278A1 (de) 1970-09-17
GB1167993A (en) 1969-10-22
FR6729M (cs) 1969-02-24
BE700231A (cs) 1967-12-01
SE357561B (cs) 1973-07-02
US3484521A (en) 1969-12-16
CH487166A (de) 1970-03-15
NO125632B (cs) 1972-10-09
GR33409B (el) 1967-11-30
ES341109A1 (es) 1968-10-01
US3438968A (en) 1969-04-15

Similar Documents

Publication Publication Date Title
FR6729M (cs)
AU5917865A (cs)
AU428063B2 (cs)
AU1141566A (cs)
AU433222B2 (cs)
AU1144366A (cs)
AU5895065A (cs)
AU6703465A (cs)
AU1111066A (cs)
BE666282A (cs)
BE618801A (cs)
BE692227A (cs)
BE689907A (cs)
BE675173A (cs)
BE675139A (cs)
BE675084A (cs)
BE674987A (cs)
BE674882A (cs)
BE674792A (cs)
BE674777A (cs)
BE674713A (cs)
BE673316A (cs)
BE692975A (cs)
BE662818A (cs)
BE654686A (cs)